PortfoliosLab logo

Ampio Pharmaceuticals, Inc. (AMPE)

Equity · Currency in USD · Last updated Mar 18, 2023

Share Price Chart


Loading data...

Performance

The chart shows the growth of $10,000 invested in Ampio Pharmaceuticals, Inc. in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $106 for a total return of roughly -98.94%. All prices are adjusted for splits and dividends.


-80.00%-60.00%-40.00%-20.00%0.00%20.00%NovemberDecember2023FebruaryMarch
-74.94%
6.48%
AMPE (Ampio Pharmaceuticals, Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with AMPE

Ampio Pharmaceuticals, Inc.

Return

Ampio Pharmaceuticals, Inc. had a return of -4.35% year-to-date (YTD) and -96.67% in the last 12 months. Over the past 10 years, Ampio Pharmaceuticals, Inc. had an annualized return of -42.13%, while the S&P 500 had an annualized return of 9.71%, indicating that Ampio Pharmaceuticals, Inc. did not perform as well as the benchmark.


PeriodReturnBenchmark
1 month-24.11%-5.31%
Year-To-Date-4.35%2.01%
6 months-85.14%0.39%
1 year-96.67%-10.12%
5 years (annualized)-64.66%7.32%
10 years (annualized)-42.13%9.71%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
202321.74%-7.14%
2022-40.10%-41.82%-22.35%-43.90%

Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Ampio Pharmaceuticals, Inc. Sharpe ratio is -0.62. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-0.90-0.80-0.70-0.60-0.50-0.40-0.30-0.20NovemberDecember2023FebruaryMarch
-0.62
-0.43
AMPE (Ampio Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Dividend History


Ampio Pharmaceuticals, Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%NovemberDecember2023FebruaryMarch
-99.82%
-18.34%
AMPE (Ampio Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Ampio Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Ampio Pharmaceuticals, Inc. is 99.82%, recorded on Dec 21, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.82%Oct 25, 20132306Dec 21, 2022
-77.78%Apr 5, 201088Aug 6, 2010121Jan 28, 2011209
-72.14%Sep 19, 2011166May 15, 2012363Oct 24, 2013529
-68%Mar 14, 20118Mar 23, 2011121Sep 14, 2011129
-20%Feb 16, 20112Feb 17, 20112Feb 22, 20114
-14.29%Aug 1, 200897Dec 30, 2008299Mar 10, 2010396
-10.26%Mar 3, 20111Mar 3, 20113Mar 8, 20114
-6.45%Feb 28, 20111Feb 28, 20112Mar 2, 20113
-5.51%Feb 2, 20113Feb 4, 20114Feb 10, 20117

Volatility Chart

Current Ampio Pharmaceuticals, Inc. volatility is 173.27%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%100.00%200.00%300.00%400.00%500.00%600.00%NovemberDecember2023FebruaryMarch
173.27%
21.17%
AMPE (Ampio Pharmaceuticals, Inc.)
Benchmark (^GSPC)